Journal Article

Comparison of GATK and DeepVariant by trio sequencing

Hsu, Ching, Chien, Yin-Hsiu, Hung, Miao-Zi, Hwu, Wuh-Liang, Chang, Pi-Chuan, Lin, Yi-Lin, Lai, FeiPei, Lee, Ni-Chung

2022

Overview

While next-generation sequencing (NGS) has transformed genetic testing, it generates large quantities of noisy data that require a significant amount of bioinformatics to generate useful interpretation. The accuracy of variant calling is therefore critical. Although GATK HaplotypeCaller is a widely used tool for this purpose, newer methods such as DeepVariant have shown higher accuracy in assessments of gold-standard samples for whole-genome sequencing (WGS) and whole-exome sequencing (WES), but a side-by-side comparison on clinical samples has not been performed. Trio WES was used to compare GATK (4.1.2.0) HaplotypeCaller and DeepVariant (v0.8.0). The performance of the two pipelines was evaluated according to the Mendelian error rate, transition-to-transversion (Ti/Tv) ratio, concordance rate, and pathological variant detection rate. Data from 80 trios were analyzed. The Mendelian error rate of the 77 biological trios calculated from the data by DeepVariant (3.09 ± 0.83%) was lower than that calculated from the data by GATK (5.25 ± 0.91%) (p < 0.001). DeepVariant also yielded a higher Ti/Tv ratio (2.38 ± 0.02) than GATK (2.04 ± 0.07) (p < 0.001), suggesting that DeepVariant proportionally called more true positives. The concordance rate between the 2 pipelines was 88.73%. Sixty-three disease-causing variants were detected in the 80 trios. Among them, DeepVariant detected 62 variants, and GATK detected 61 variants. The one variant called by DeepVariant but not GATK HaplotypeCaller might have been missed by GATK HaplotypeCaller due to low coverage. OTC exon 2 (139 bp) deletion was not detected by either method. Mendelian error rate calculation is an effective way to evaluate variant callers. By this method, DeepVariant outperformed GATK, while the two pipelines performed equally in other parameters.

• Publisher: Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
• Subject: 631/114 / 631/208 / 692/4017 / Bioinformatics / Case-Control Studies / Computational Biology - methods / Genetic Diseases, Inborn - diagnosis / Genetic Diseases, Inborn - genetics / Genetic Predisposition to Disease / Genetic screening / Genetic Variation / Genomes / Haplotypes / Heredity / High-Throughput Nucleotide Sequencing / Humanities and Social Sciences / Humans / multidisciplinary / Next-generation sequencing / Pedigree / Predictive Value of Tests / Reproducibility of Results / Science / Science (multidisciplinary) / Software / Transversion / Whole Exome Sequencing / Whole genome sequencing